Clinical trials: sponsored by GE Healthcare
Cardiac CT
Clinical Data Collection and Evaluation of ECG-Less Cardiac CT
The primary objective of this study is to collect CT scan data without ECG-leads attached to the human subject. This data is intended to represent a typical range of clinical scenarios in which Cardiac CT imaging is used.
- Trial name
- NCT05949138
- Testing
- ECG-Less Cardiac CT using SmartPhase
- Where
- 2 sites in United States
- Volunteers
- 56 people
- Sponsor
- GE Healthcare
Oncology
Evaluation of a New Generation of PET-CT OMNI
The overarching purpose of the study is to provide supporting evidence to the value proposition of OMNI, that offers global access to an affordable hybrid PET/CT system similar in performance to that of systems utilized by…
- Trial name
- NCT05154877
- Testing
- OMNI PET/CT Scan
- Where
- France
- Volunteers
- 45 people
- Sponsor
- GE Healthcare
Transthoracic Echocardiography, Suspected or Known Structural or Functional Cardiac Abnormality
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
Study to determine the safety and appropriate dosage of OPTISON in pediatric participants since OPTISON has been tested in adult participants only during the clinical development
- Trial name
- NCT03740997
- Testing
- Optison
- Where
- 8 sites in United States
- Volunteers
- 39 people
- Sponsor
- GE Healthcare
Cardiovascular Diseases
Dual Energy Cardiac CT Data Collection and Evaluation
This study is intended to collect clinical feasibility data using this prototype research mode for the purposes of understanding potential clinical impact, potential limitations and strengths, and to further develop the technique…
- Trial name
- NCT05171764
- Testing
- Additional Gemstone Spectral Imaging (GSI) cardiac scan
- Where
- Switzerland
- Volunteers
- 30 people
- Sponsor
- GE Healthcare
Parkinsonian Syndrome, Parkinson Disease(PD)
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
This is a multicenter, open-label, non-controlled, non-randomized, phase 3 clinical study to compare the SPECT findings after a single IV administration of DaTSCAN™ ioflupane (123I) injection for patients with a clinical…
- Conditions
- Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP)
- Trial name
- NCT04193527
- Testing
- DaTSCAN™ Ioflupane (123I) Injection
- Where
- 10 sites in China
- Volunteers
- 172 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Healthy Subjects (HS)
A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.
This is a phase 1, single-centre, single-group, nonrandomized, noncomparative, open-label, single-dose study to evaluate the safety, biodistribution, internal radiation dosimetry, and effective dose of DaTSCAN™ ioflupane (123I)…
- Trial name
- NCT04564092
- Testing
- DaTSCAN™ Ioflupane (123I) Injection
- Where
- China
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Coronary Artery Disease (CAD), Ischemic Heart Disease
A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes
This was a Phase 2 prospective, randomized, crossover study of Flurpiridaz (18F) Injection for PET-MPI in participants referred for evaluation of known coronary artery disease (CAD) or for suspected CAD with intermediate to high…
- Trial name
- NCT04594941
- Testing
- Flurpiridaz (18F) Injection
- Where
- 5 sites in United States
- Volunteers
- 38 people
- Sponsor
- GE Healthcare
Coronary Artery Disease (CAD)
An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.
- Trial name
- NCT03354273
- Testing
- PET MPI, SPECT MPI, Pharmacological stress agents
- Where
- 53 sites in United States, Canada and 5 more
- Volunteers
- 730 people
- Sponsor
- GE Healthcare
Pharmacokinetics
Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers
This is a single center, prospective, dose escalation study (4 different dose levels) for a novel magnetic resonance imaging (MRI) contrast agent, in male and female healthy volunteers .
- Trial name
- NCT05569278
- Testing
- GE200486 0.5M Injection
- Where
- Norway
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Breast Cancer
Clinical Data Collection in Breast Tomosynthesis (COBRIS)
The purpose of the study is to assess an image acquisition application for breast tomosynthesis in a clinical environment
- Trial name
- COBRIS (NCT05914168)
- Testing
- Breast Tomosynthesis
- Where
- France
- Volunteers
- 150 people
- Sponsor
- GE Healthcare
Ultrasound Exams
Development Of Medical Ultrasound Systems, Accessories, And Components - GE Bangalore
Ultrasound devices components and accessories are under continuous development in order to optimize, validate and improve the devices, including improving the quality of images.
- Trial name
- NCT02946242
- Testing
- Ultrasound Exam
- Where
- India
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Blood Pressure
Data Collection for Validation of an NIBP Algorithm in Pregnant Women
The purpose of the study is to collect per subject blood pressure data on the device's intended population as described in the International Organization for Standardization (ISO) Standard 81060-2:2018+A1:2020 Non-invasive…
- Trial name
- NCT05789849
- Testing
- Collecting blood pressure measurements with noninvasive blood pressure device
- Where
- United States
- Volunteers
- 170 people
- Sponsor
- GE Healthcare
Echocardiography
GE CVUS Device Evaluation
The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device.
- Trial name
- NCT05340244
- Testing
- Investigational ultrasound exam
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- GE Healthcare
Et Control Performance in Adult Population Surgery
Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
This is a clinical, single blind, randomized, prospective research study. The purpose of this pivotal study is to collect and analyze data on the investigational End tidal Control (Et Control) option feature.
- Trial name
- NCT02972892
- Testing
- Et Control Feature, Conventional Fresh Gas
- Where
- 4 sites in United States
- Volunteers
- 248 people
- Sponsor
- GE Healthcare
Healthy
Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias
This protocol focuses on the evaluation of the GE noninvasive blood pressure parameter in subjects with dysrhythmias and normal sinus rhythm. The study follows the recommendations of the ANSI/AAMI SP10 Standard.
- Trial name
- NCT00443001
- Testing
- Non invasive blood pressure monitor
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Oncology
Demonstration Of A Next Generation PET CT System
The intent of this evaluation is to obtain user feedback on device performance, user preference, image quality, workflow, and new device features, a necessary part of product development.
- Trial name
- NCT05122715
- Testing
- Additional PET/CT Scan
- Where
- Israel
- Volunteers
- 70 people
- Sponsor
- GE Healthcare
Hypothyroidism
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
This is a Phase 4 multicenter prospective study to estimate the proportion of patients aged birth to 3 years who develop hypothyroidism within 6 months after receiving intravascular iohexol (Omnipaque™), iodixanol (Visipaque™)…
- Trial name
- NCT03631771
- Testing
- Iohexol, Iodixanol, Iopromide
- Sponsor
- GE Healthcare
Coronary Artery Disease, ST-segment Elevation Myocardial Infarction
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
The purpose of this study is to prospectively observe the incidence rate of acute kidney injury (AKI), major adverse renal and cardiovascular events (MARCE) in participants who were diagnosed with ST-segment elevation myocardial…
- Trial name
- NCT03671603
- Testing
- Iodixanol
- Where
- 36 sites in China, South Korea
- Volunteers
- 2,755 people
- Sponsor
- GE Healthcare
Patient Monitoring
AMS Evaluation Study
A study to evaluate the operational and functional features of the Ambulatory Monitor Solution (AMS) as well as the ease of use of the system.
- Trial name
- NCT04472208
- Testing
- Ambulatory monitoring solution
- Where
- United Kingdom
- Volunteers
- 34 people
- Sponsor
- GE Healthcare
Patient Monitoring
Feasibility Study Of Ambulatory Monitoring System
This is a clinical, data collection study conducted at one site. This study will collect open comments, user feedback and parameter raw data to support patient monitoring product development.
- Trial name
- NCT04959136
- Testing
- Ambulatory Monitoring Solution
- Volunteers
- 300 people
- Sponsor
- GE Healthcare